h1

h2

h3

h4

h5
h6

001     1005974
005     20250318115459.0
024 7 _ |2 ISSN
|a 1526-9655
024 7 _ |2 ISSN
|a 1557-9190
024 7 _ |2 ISSN
|a 1938-0712
024 7 _ |2 ISSN
|a 2152-2650
024 7 _ |2 ISSN
|a 2152-2669
024 7 _ |2 ISSN
|a 2331-4486
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85208591342
024 7 _ |2 WOS
|a WOS:001427360500001
024 7 _ |2 datacite_doi
|a 10.18154/RWTH-2025-02142
024 7 _ |2 doi
|a 10.1016/j.clml.2024.10.001
037 _ _ |a RWTH-2025-02142
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Harrison, Claire N.
|b 0
|e Corresponding author
245 _ _ |a Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib
|h online, print
260 _ _ |a Dallas, Tex.
|b Cancer Information Group
|c 2025
260 _ _ |c 2024
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
500 _ _ |a Available online 16 October 2024
588 _ _ |a Dataset connected to , , , CrossRef, Journals: publications.rwth-aachen.de
591 _ _ |a Australia
591 _ _ |a Canada
591 _ _ |a Germany
591 _ _ |a Italy
591 _ _ |a Singapore
591 _ _ |a South Korea
591 _ _ |a Spain
591 _ _ |a UK
591 _ _ |a USA
700 1 _ |a Mesa, Ruben
|b 1
700 1 _ |0 0000-0003-3361-3981
|a Talpaz, Moshe
|b 2
700 1 _ |a Gupta, Vikas
|b 3
700 1 _ |a Gerds, Aaron T.
|b 4
700 1 _ |a Perkins, Andrew
|b 5
700 1 _ |a Goh, Yeow Tee
|b 6
700 1 _ |a Fox, Maria Laura
|b 7
700 1 _ |a McLornan, Donal
|b 8
700 1 _ |a Palmer, Jeanne
|b 9
700 1 _ |a Foltz, Lynda
|b 10
700 1 _ |a Vannucchi, Alessandro
|b 11
700 1 _ |0 P:(DE-82)IDM06178
|a Koschmieder, Steffen
|b 12
|u rwth
700 1 _ |a Passamonti, Francesco
|b 13
700 1 _ |a Lee, Sung-Eun
|b 14
700 1 _ |a Ellis, Catherine
|b 15
700 1 _ |a Strouse, Bryan
|b 16
700 1 _ |a Gonzalez Carreras, Francisco J.
|b 17
700 1 _ |a Oh, Stephen T.
|b 18
773 _ _ |0 PERI:(DE-600)2540998-0
|a 10.1016/j.clml.2024.10.001
|n 3
|p 199-211
|t Clinical lymphoma, myeloma & leukemia
|v 25
|x 2152-2669
|y 2025
856 4 _ |u https://publications.rwth-aachen.de/record/1005974/files/1005974.pdf
|y OpenAccess
909 C O |o oai:publications.rwth-aachen.de:1005974
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06178
|a RWTH Aachen
|b 12
|k RWTH
914 1 _ |y 2024
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b CL LYMPH MYELOM LEUK : 2022
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2024-12-13
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2024-12-13
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2 ; 933110
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)
|x 0
920 1 _ |0 I:(DE-82)531040-3_20140620
|k 531040-3 ; 933210
|l Lehr- und Forschungsgebiet Translationale Hämatologie und Onkologie
|x 1
980 1 _ |a FullTexts
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a I:(DE-82)531040-3_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21